Ling Yan
Impact in
-
- Cardiac Fibrosis and Remodeling
- Chemotherapy-induced cardiotoxicity and mitigation
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
Papers in
-
- Cardiac Fibrosis and Remodeling 26
-
- S100 Proteins and Annexins 5
- Extracellular vesicles in disease 4
- Protein Tyrosine Phosphatases 3
- Co-authors
- Hongyang Wang (5 shared papers)Zhou‐Yan Bian (25 shared papers)Le‐Xing Yu (3 shared papers)Hongliang Li (21 shared papers)Qizhu Tang (16 shared papers)Qi‐Zhu Tang (6 shared papers)Zhi‐Gang She (14 shared papers)Chun‐Yan Kong (4 shared papers)
- Journals
- Hypertension (6 papers)Journal of Cellular Biochemistry (5 papers)PLoS ONE (4 papers)Journal of Cellular and Molecular Medicine (3 papers)Medicine (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ling Yan
136 papers receiving 4k citations
Ling Yan's Hit Papers
Peers
Comparison fields: 5 of 128
- Cardiology and Cardiovascular Medicine 792
- Clinical Biochemistry 114
- Hepatology 165
- Cancer Research 215
- Immunology 278
Countries citing papers authored by Ling Yan
This map shows the geographic impact of Ling Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Yan more than expected).
Fields of papers citing papers by Ling Yan
This network shows the impact of papers produced by Ling Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Yan. The network helps show where Ling Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death Hit paper breakdown → | 2021 | 292 |
| 2 | 2018 | 248 | |
| 3 | 2019 | 187 | |
| 4 | 2014 | 160 | |
| 5 | 2019 | 118 | |
| 6 | 2022 | 112 | |
| 7 | 2010 | 98 | |
| 8 | 2019 | 87 | |
| 9 | 2022 | 84 | |
| 10 | 2008 | 80 | |
| 11 | 2011 | 79 | |
| 12 | 2009 | 77 | |
| 13 | 2008 | 72 | |
| 14 | 2012 | 68 | |
| 15 | 2013 | 68 | |
| 16 | 2020 | 65 | |
| 17 | 2010 | 63 | |
| 18 | 2008 | 57 | |
| 19 | 2005 | 56 | |
| 20 | 2009 | 55 |
About Ling Yan
Ling Yan is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Clinical Biochemistry, Oncology and Pathology and Forensic Medicine, having authored 148 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (26 papers), S100 Proteins and Annexins (5 papers), Advanced Glycation End Products research (5 papers), Extracellular vesicles in disease (4 papers), Protein Tyrosine Phosphatases (3 papers), Multiple Sclerosis Research Studies (3 papers), AI in cancer detection (3 papers) and Natural Antidiabetic Agents Studies (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (792 citations), Clinical Biochemistry (114 citations), Hepatology (165 citations), Cancer Research (215 citations) and Immunology (278 citations). Ling Yan has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Hongyang Wang, Zhou‐Yan Bian, Le‐Xing Yu, Hongliang Li, Qizhu Tang, Qi‐Zhu Tang, Zhi‐Gang She, Chun‐Yan Kong, David R. Clemmons and Laura A. Maile. Their work appears in journals such as Hypertension, Journal of Cellular Biochemistry, PLoS ONE, Journal of Cellular and Molecular Medicine and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.